April 19, 2018 / 12:45 PM / 3 months ago

BRIEF-Hemostemix Announces U.S. FDA Clinical Trial Approval

April 19 (Reuters) - Hemostemix Inc:

* HEMOSTEMIX ANNOUNCES US FDA CLINICAL TRIAL APPROVAL

* HEMOSTEMIX INC - UNITED STATES FOOD AND DRUG ADMINISTRATION HAS RAISED NO OBJECTIONS TO COMPANY'S INVESTIGATIONAL NEW DRUG APPLICATION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below